Accenture wraps up Octagon buyout; NextBio aids cancer researchers;

> NextBio, a provider of bioinformatics for genomics researchers, has inked a partnership with Emory University and its Winship Cancer Institute focused on hunting for biomarkers and treatments for multiple myeloma. Release

> Accenture, the global consulting and tech services giant, says it has completed its acquisition of clinical and regulatory technology provider Octagon Research Solutions. Article

> Molplex, a Newcastle, U.K., life sciences company that uses predictive chemistry software as part of its drug discovery services, has won £350,000 ($565,075) from the North West Fund. Article

> Virtify, a provider of content management software for life sciences, and Forte Research Systems, which offers a clinical research management system, plan to integrate their software. Release

> Quintiles, the CRO giant, has added interactive, role-based navigation as a new twist to its Infosario reporting and analytics platform. Item

Sponsored By Metabolon

Five Translational Insights Key to a Successful First-in-Human (FIH) Study – Metabolite-Based Biomarker Discovery and Validation

Translational success rates from pre-clinical animal studies to human clinical trials remain frustratingly low. Learn how metabolomics helps you bridge between the theoretical & practical, between the function & actual activity of your drug molecule to get you closer to the phenotype, sooner.